1. |
Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab, 2013, 98(3): 1122-1129.
|
2. |
王滟, 张劲松, 缪刚, 等. 原发性甲状旁腺功能亢进的临床特征分析. 中国全科医学, 2018, 21(35): 4392-4396.
|
3. |
周建平, 张浩, 董明. 原发性甲状旁腺功能亢进症手术方式的选择. 中国普通外科杂志, 2008, 17(11): 1121-1123.
|
4. |
Richards ML, Thompson GB, Farley DR, et al. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg, 2011, 146(3): 280-285.
|
5. |
姚晓爱, 昌红, 姜涛, 等. 140例原发性甲状旁腺功能亢进患者临床资料分析. 中国肿瘤临床, 2016, 43(23): 1035-1039.
|
6. |
Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol, 2018, 14(2): 115-125.
|
7. |
崔铭, 王鸥, 廖泉. 原发性甲状旁腺功能亢进症诊断及手术治疗进展. 协和医学杂志, 2020, 11(4): 395-401.
|
8. |
Romei C, Pardi E, Cetani F, et al. Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J Oncol, 2012, 2012: 705036.
|
9. |
王鸥, 邢小平, 孟迅吾, 等. 无症状型原发性甲状旁腺功能亢进症临床特点分析. 中华骨质疏松和骨矿盐疾病杂志, 2010, 3(1): 18-22.
|
10. |
Cetani F, Pardi E, Marcocci C. Parathyroid carcinoma. Front Horm Res, 2019, 51: 63-76.
|
11. |
Christakis I, Bussaidy N, Clarke C, et al. Differentiating atypical parathyroid neoplasm from parathyroid cancer. Ann Surg Oncol, 2016, 23(9): 2889-2897.
|
12. |
Kruijff S, Sidhu SB, Sywak MS, et al. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol, 2014, 21(2): 426-433.
|
13. |
田雨霖. 原发性甲状旁腺功能亢进症的诊断与外科治疗. 中国实用外科杂志, 2008, 28(3): 221-223.
|
14. |
Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg, 2007, 246(6): 976-980.
|
15. |
Smit PC, Borel Rinkes IH, van Dalen A, et al. Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration? Ann Surg, 2000, 231(4): 559-565.
|
16. |
徐少明. 积极开展原发性甲状旁腺功能亢进症的微创外科治疗. 中华医学杂志, 2003, 83(11): 925-926.
|
17. |
李朋, 韦伟. 原发性甲状旁腺功能亢进诊治的难点与进展. 临床外科杂志, 2020, 28(3): 208-210.
|
18. |
中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组, 中华医学会骨质疏松和骨矿盐疾病分会, 等. 原发性甲状旁腺功能亢进症诊疗指南. 中华骨质疏松和骨矿盐疾病杂志, 2014, 7(3): 187-198.
|
19. |
胡亚, 廖泉, 牛哲禹, 等. 甲状旁腺功能亢进合并分化型甲状腺癌384例诊治分析. 中国实用外科杂志, 2014, 34(4): 329-331.
|
20. |
Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg, 2016, 151(10): 959-968.
|
21. |
Di Marco A, Mechera R, Glover A, et al. Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach? Surgery, 2021, 170(5): 1383-1388.
|
22. |
Calò PG, Pisano G, Tatti A, et al. Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism: is it really mandatory? Minerva Chir, 2012, 67(4): 337-342.
|
23. |
Heller KS, Blumberg SN. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy. Arch Otolaryngol Head Neck Surg, 2009, 135(11): 1103-1107.
|
24. |
廖泉, 胡亚, 赵玉沛. 小切口甲状旁腺手术. 中华外科杂志, 2015, 53(3): 164-166.
|
25. |
Najafian A, Kahan S, Olson MT, et al. Intraoperative PTH may not be necessary in the management of primary hyperparathyroidism even with only one positive or only indeterminate preoperative localization studies. World J Surg, 2017, 41(6): 1500-1505.
|
26. |
黄盛, 刘晓芳, 谢飞来, 等. 术前立体定位在继发性甲状旁腺功能亢进症手术中的应用. 中国普外基础与临床杂志, 2021, 28(2): 219-223.
|
27. |
Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol, 2013, 168(3): R45-R53.
|
28. |
朱信心, 魏涛, 龚日祥, 等. 136例原发性甲状旁腺功能亢进的诊治体会. 中国普外基础与临床杂志, 2014, 21(4): 452-457.
|